Jump to navigation Jump to search

Template:Infobox Company

WikiDoc Resources for Medtronic


Most recent articles on Medtronic

Most cited articles on Medtronic

Review articles on Medtronic

Articles on Medtronic in N Eng J Med, Lancet, BMJ


Powerpoint slides on Medtronic

Images of Medtronic

Photos of Medtronic

Podcasts & MP3s on Medtronic

Videos on Medtronic

Evidence Based Medicine

Cochrane Collaboration on Medtronic

Bandolier on Medtronic

TRIP on Medtronic

Clinical Trials

Ongoing Trials on Medtronic at Clinical

Trial results on Medtronic

Clinical Trials on Medtronic at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Medtronic

NICE Guidance on Medtronic


FDA on Medtronic

CDC on Medtronic


Books on Medtronic


Medtronic in the news

Be alerted to news on Medtronic

News trends on Medtronic


Blogs on Medtronic


Definitions of Medtronic

Patient Resources / Community

Patient resources on Medtronic

Discussion groups on Medtronic

Patient Handouts on Medtronic

Directions to Hospitals Treating Medtronic

Risk calculators and risk factors for Medtronic

Healthcare Provider Resources

Symptoms of Medtronic

Causes & Risk Factors for Medtronic

Diagnostic studies for Medtronic

Treatment of Medtronic

Continuing Medical Education (CME)

CME Programs on Medtronic


Medtronic en Espanol

Medtronic en Francais


Medtronic in the Marketplace

Patents on Medtronic

Experimental / Informatics

List of terms related to Medtronic

Medtronic, Inc. (Template:Nyse), based in Fridley, Minnesota, is the world's largest medical technology company. Listed among Fortune 500 companies, Medtronic is a publicly traded company and is listed on the New York Stock Exchange under the symbol MDT. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and is credited with manufacturing the first wearable artificial pacemakers. However, they started off with much more modest intentions, acting as a repair company, servicing medical equipment in local hospitals. Medtronic's main competitors for cardiac devices are Guidant (now a division of Boston Scientific) and St. Jude Medical.

Medtronic followed a path familiar to technology historians, starting in a garage in northern Minneapolis. The company expanded through the 1950s, mostly selling equipment built by other companies, but some custom hardware was also developed. The employees eventually came to know Dr. C. Walton Lillehei, a noted heart surgeon who was then at the University of Minnesota. Dr. Lillehei was frustrated with the pacemakers of the day, which relied on wall current to operate. This was extremely troublesome because power outages would cause patients to die.

Bakken built a small transistorized pacemaker that could be strapped to the body and powered by batteries. Work into this new field continued, producing an implantable pacemaker in 1960.

The company has continued to innovate in the medical business and is considered an economically-important company for Minnesota. A key attribute in understanding the company is that it remains very focused on the mission originally written by co-founder Earl Bakken in the early-1960s. The first paragraph of the 6 paragraph mission statement reads:

"To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life."

Medtronic makes a wide array of implantable electronic devices, from the relatively common ICD or implantable cardioverter-defibrillator, to devices for managing urinary incontinence and obesity to name just a few.

Medtronic Diabetes

Medtronic Diabetes is the diabetes management manufacturing and sales division of Medtronic based in Northridge, California. The original company Minimed Technologies was founded in the early 1980s and spun-off from Pacesetter Systems, in order to design a practical insulin pump for lifelong wear. Most devices at the time were either too large or impossible to program and extremely unreliable. The release of the lightweight, menu-driven MiniMed 500 series changed the landscape, and was a major factor in bringing pump usage to the mainstream. By the early 2000s Medtronic had bought out Minimed to form Medtronic Minimed.

Current models consist of the MiniMed Paradigm 522/722. It is the first Insulin Pump which integrates continuous glucose monitoring, allowing patients to see in real time their glucose level. As well as insulin pumps Medtronic Diabetes also makes Continuous Blood Glucose Monitoring Systems (CGMS) for use as a stand alone system or integrated into their Minimed Paradigm 522/722 series pumps. Medtronic Diabetes also makes a large range of accessories and components for their insulin pump and CGMS products.

The Former Medtronic Minimed logo

As of March 2007 the MiniMed name has begun to be absorbed into the parent company, Medtronic. Medtronic has kept the MiniMed name to brand their insulin pumps, for example: The MiniMed Paradigm 722. Medtronic frequently uses Medtronic Diabetes as the name for the division, it is unclear to the extent the division will be integrated into Medtronic, as it still maintains its own website. Many products and marketing material still say Medtronic MiniMed, as the brand is being phased out.

See also

External links

Template:Minnesota Corporations

de:Medtronic nl:Medtronic Template:WH Template:WikiDoc Sources